The Value of EP Device Registry Data: Impacting Care Delivery with Data and Metrics - 2022 Quality Summit presentation (Non-CE)-The Value of EP Device Registry Data: Impacting Care Delivery with Data and Metrics

Video Transcription

Video Summary

In the video, Dr. Amir Youssef discusses the value of the EP device registry data and its impact on care delivery. The EP device registry was implemented in 2005 to support reimbursements for patients enrolled in clinical trials or post-clinical trials for E.P. devices. The registry collects data on all ICD implants regardless of indication and is a comprehensive source of data with over 2 million ICD implants recorded. Dr. Youssef explains that the registry has led to a better understanding of outcomes and has significantly impacted device selection, outcomes, effectiveness, safety, equity, and efficiency of care. The registry has also become a model for other cardiovascular procedures such as transcatheter valve registry, a fib ablation, and left atrial appendage closure devices.<br /><br />Dr. Youssef emphasizes the importance of appropriate use criteria (AUC) in care delivery. AUC evaluates overall patterns of care and identifies areas of overuse and uncertainty in indications. He explains that the AUCs are not meant to be mandates but serve as evidence-based guidelines for clinicians. The AUCs are incorporated into the EP device registry and performance reports are provided to participating hospitals, allowing benchmarking of individual and institutional performance. Dr. Youssef also discusses the impact of AUC on patient care, reimbursement, and quality improvement. He concludes by stating that the EP device registry and AUCs have improved care delivery and provided a model for transparency, accountability, and advancement in science.

Keywords

EP device registry

data

care delivery

ICD implants

outcomes

device selection

appropriate use criteria